Short interest in Lineage Cell Therapeutics Inc (AMEX:LCTX) decreased during the last reporting period, falling from 27.11M to 21.30M. This put 14.79% of the company's publicly available shares short.

Short interest for Lineage Cell Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Lineage Cell Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.82M shares traded per day, it would take 11.68 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.